https://www.selleckchem.com/pr....oducts/sodium-cholat
The Hemraude study was conducted to describe the profile of patients with HA, disease management, and economic burden in a collective perspective. This retrospective study was conducted using the French administrative healthcare claims database SNIIRAM/SNDS. Male patients treated for hemophilia A with a long-term illness (ALD) status or invalidity were included in the study between January 1, 2016 and December 31, 2017. Patients were classified in six treatment groups no treatment, on-demand FVIII, prophylactic FVIII, FVIII in im
Me gusta
Comentario
Compartir
